>>> Up
* BCP Upgraded to Buy at JB Capital Markets; PT 29 Cents
* Bouygues Upgraded to Overweight at Barclays; PT 44 Euros
* DNB Upgraded to Buy at Berenberg
* Homeserve Upgraded to Outperform at RBC; PT 15 Pounds
* Investor AB Upgraded to Add at AlphaValue
* SSE Upgraded to Equal-weight at Barclays; PT 13 Pounds
>>> Down
* ABN AMRO Bank GDRs Downgraded to Outperform at RBC; PT 21 Euros
* Cellnex Cut to Equal-weight at Morgan Stanley; PT 41 Euros
* Demant Downgraded to Add at AlphaValue
* Mediobanca Downgraded to Reduce at AlphaValue
* Pearson Downgraded to Reduce at AlphaValue
* PowerCell Sweden Cut to Hold at Pareto Securities; PT 105 Kronor
* Salzgitter Downgraded to Sell at AlphaValue
* Valora Downgraded to Underperform at MainFirst; PT 240 Francs
* Whitbread Cut to Equal-weight at Barclays; PT 43.50 Pounds
>>> Initiation
* Abcam Rated New Hold at Liberum; PT 12.30 Pounds
* Cello Health Rated New Hold at Liberum; PT 1.35 Pounds
* Clinigen Rated New Hold at Liberum; PT 10 Pounds
* Huntsworth Rated New Buy at Liberum; PT 1.20 Pounds
* Novozymes Downgraded to Underweight at JPMorgan; PT 270 Kroner
* Oxford Biomedica Rated New Buy at Liberum; PT 8.10 Pounds
>>> Call
* DNB’s Valuation Is Undemanding, Stock Upgraded at Berenberg
* Marks & Spencer’s Problems Remain, PT to Street-Low: Berenberg
* Take Profits in Cellnex After Strong Gains, Morgan Stanley Says